понедельник, 18 февраля 2013 г.

FDA didn’t utilize its authority to prevent meningitis outbreak


The meningitis outbreak resulted from contaminated epidural steroid injections could have been avoided. But since the FDA didn’t use its authority for this purpose suitably, more than 500 persons were contaminated with this disease and 39 recipients of the injections died.
Tennessee officials turned out to show unbelievable competence under such circumstances. They were praised by legislators for their decisive actions.
It was reported that numerous persons that had been given steroid injections produced by the NECC experienced complications. When Tennessee health officials were informed about this situation, they enforced all health facilities to stop utilizing medications produced by the compounding pharmacy from Massachusetts. Furthermore, they informed immediately about contamination health officials of other states. Actions of Tennessee health officials were rapid and definite. They didn’t hesitate and did everything in order to prevent further contamination and improve help those that were already contaminated with meningitis.
If Tennessee health officials hadn’t been so decisive and competent, more persons would have been contaminated with fungal meningitis and more deaths would have been.
As for the FDA, it showed incompetence. It didn’t use its power definitely in order to improve the situation. Then it tried to justify its negligence, saying that its authority was not cleared and established enough to influence on such large-scale compounding centers, as the NECC. But legislators didn’t accept the FDA’s excuse.
Tennessee health officials merit acquiring a gold medal for their actions.
Although certain individuals believe that they could avoid contamination, warnings about risks continue to exist. Numerous persons are still at the hospital. Others are visited by health officials. If any side results occur at injection sites of those that have applied the tainted steroids, they must contact physicians at once.

Комментариев нет:

Отправить комментарий